However, in humans, circulating FGF21 levels are often elevated in different pathophysiological conditions such as metabolic syndrome, obesity, dyslipidemia, insulin resistance, type 2 diabetes, non-alcoholic fatty liver disease and coronary artery disease5. This evidence concerns the gene FGF21 and metabolic syndrome.